MedPath

Effect of 7% hypertonic saline in bronchiolitis

Phase 3
Conditions
Health Condition 1: J219- Acute bronchiolitis, unspecified
Registration Number
CTRI/2022/12/048606
Lead Sponsor
ONE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Children aged 1-24 months of age

2. Diagnosed with bronchiolitis- defined as viral prodrome for 2-3 days followed by LRTI as tachypnea, bilateral wheeze/ crepitations with or without crepitations

3. Bronchiolitis severity score more than or equal to 4

Exclusion Criteria

1. A previous history of wheezing/ diagnosis of asthma

2.Any use of bronchodilators within 2 hours of presentation

3.History of congenital heart disease/ chronic pulmonary disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath